The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis

被引：0
|
作者：
Carolyn H. Goldschmidt
Jeffrey A. Cohen
机构：
[1] Cleveland Clinic,Mellen Center U
来源：
Neurotherapeutics | 2020年 / 17卷
关键词：
Biotin; multiple sclerosis; progressive MS; MS relapse;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：968 / 970
页数：2
相关论文
共 50 条
  • [1] The Rise and Fall of High-Dose Biotin to Treat Progressive Multiple Sclerosis
    Goldschmidt, Carolyn H.
    Cohen, Jeffrey A.
    [J]. NEUROTHERAPEUTICS, 2020, 17 (03) : 968 - 970
  • [2] Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
    Mathais, Sophie
    Moisset, Xavier
    Pereira, Bruno
    Taithe, Frederic
    Ciron, Jonathan
    Labauge, Pierre
    Dulau, Cecile
    Laplaud, David
    De Seze, Jerome
    Pelletier, Jean
    Berger, Eric
    Lebrun-Frenay, Christine
    Castelnovo, Giovanni
    Edan, Gilles
    Defer, Gilles
    Vermersch, Patrick
    Bourre, Bertrand
    Camdessanche, Jean-Philippe
    Magy, Laurent
    Guennoc, Anne-Marie
    Mathey, Guillaume
    Moreau, Thibault
    Gout, Olivier
    Heinzlef, Olivier
    Maillart, Elisabeth
    Vukusic, Sandra
    Clavelou, Pierre
    [J]. NEUROTHERAPEUTICS, 2021, 18 (01) : 378 - 386
  • [3] Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
    Sophie Mathais
    Xavier Moisset
    Bruno Pereira
    Frédéric Taithe
    Jonathan Ciron
    Pierre Labauge
    Cécile Dulau
    David Laplaud
    Jérôme De Seze
    Jean Pelletier
    Eric Berger
    Christine Lebrun-Frenay
    Giovanni Castelnovo
    Gilles Edan
    Gilles Defer
    Patrick Vermersch
    Bertrand Bourre
    Jean-Philippe Camdessanche
    Laurent Magy
    Anne-Marie Guennoc
    Guillaume Mathey
    Thibault Moreau
    Olivier Gout
    Olivier Heinzlef
    Elisabeth Maillart
    Sandra Vukusic
    Pierre Clavelou
    [J]. Neurotherapeutics, 2021, 18 : 378 - 386
  • [4] Breakthrough disease under high-dose biotin treatment in progressive multiple sclerosis
    Granella, F.
    Tsantes, E.
    Siena, E.
    Curti, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 376 - 376
  • [5] Severe transient myopathy in a patient with progressive multiple sclerosis and high-dose biotin
    Maillart, Elisabeth
    Mochel, Fanny
    Acquaviva, Cecile
    Maisonobe, Thierry
    Stankoff, Bruno
    [J]. NEUROLOGY, 2019, 92 (22) : 1060 - 1062
  • [6] High Dose Biotin as Treatment for Progressive Multiple Sclerosis
    Birnbaum, Gary
    Stulc, Jessica
    Snyder, Tori M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 71 - 72
  • [7] High dose biotin as treatment for progressive multiple sclerosis
    Birnbaum, Gary
    Stulc, Jessica
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 18 : 141 - 143
  • [8] Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis
    Sedel, Frederic
    Bernard, Delphine
    Mock, Donald M.
    Tourbah, Ayman
    [J]. NEUROPHARMACOLOGY, 2016, 110 : 644 - 653
  • [9] High-dose biotin in multiple sclerosis:the end of the road
    Motte, Jeremias
    Gold, Ralf
    [J]. LANCET NEUROLOGY, 2020, 19 (12): : 965 - 966
  • [10] Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis
    Saint Paul, Laure Peyro
    Debruyne, Daniele
    Bernard, Delphine
    Mock, Donald M.
    Defer, Gilles L.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (03) : 327 - 344
12345